EVIDENCE LIBRARY
Majorcan Insomnia Survey: Common Benzodiazepine Treatment Did Not Establish Symptom Control
A primary-care survey described insomnia, comorbidity, and treatment use, rather than testing whether benzodiazepines worked.
A primary-care survey described insomnia, comorbidity, and treatment use, rather than testing whether benzodiazepines worked.
What participants reported
Of 467 participating adults, approximately one fifth screened as having insomnia. Among those with insomnia, 41.1% reported usually taking pharmacological sleep treatment. Sleep hygiene and benzodiazepines were common measures, while cognitive behavioral approaches were rarely used. Pain, anxiety, and depression were also frequent.
Treatment prevalence differs from treatment success
The cross-sectional design cannot establish whether medication preceded persistent symptoms, improved them, or contributed to daytime difficulties. Noncontact and nonparticipation also limit population estimates. The 41.1% figure concerns pharmacological sleep treatment overall, not benzodiazepines alone. For an individual review, document the actual product, duration, adherence, and response rather than inferring them from a treatment category. The study describes a gap between available approaches and reported practice without proving which treatment caused an outcome.
Source paper
Original analysis of the supplied journal article, identified as PMC6930951.